With nearly 30 years of international experience Charles Ruban is a seasoned executive in the biopharmaceutical and medical industries., Charles Ruban is an expert in global healthcare. Before joining Verdot, he was the Deputy CEO of HTL Biotechnology and, the COO of DBV Technologies and an executive at Stallergenes. He has developed strategic alliances and launched biologics in markets such as Europe, the US and Japan. In addition to his professional achievements, Charles is committed in carbon footprint reduction initiatives and is a member of Citizen’s Climate Lobby.